Amgen Set to Report Q4 Earnings: What Investors Should Know [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
In the last reported quarter, the company's earnings beat expectations by 12.8%. The Zacks Consensus Estimate for fourth-quarter sales and earnings is pegged at $9.46 billion and $4.74 per share, respectively. Amgen's product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha and Blincyto, among others. However, prices of most products are expected to have declined due to higher rebates to support expanded access. Revenues in the third quarter benefited from some one-time items, like $250 million from favorable changes to U.S. estimated sales deductions and a government order for Nplate of $90 million. These benefits are likely to have been absent in the fourth quarter. The Zacks Consensus Estimate for Evenity, Repatha and Blincyto sales is pegged at $559.0 million, $798.0 million and $434.0 million, respectively. Newer drugs like Imdelltra, Tavneos and Tezspire are expected to have contributed to top-line growth driven by new pati
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves [Yahoo! Finance]Yahoo! Finance
- Steve Jobs' son says he can help end cancer deaths - and he's raising millions to do it [Yahoo! Finance]Yahoo! Finance
- Amgen (NASDAQ:AMGN) was given a new $400.00 price target on by analysts at Oppenheimer Holdings, Inc.. They now have an "outperform" rating on the stock.MarketBeat
- AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTSPR Newswire
- TransCelerate BioPharma Showcases Approaches to Advancing Clinical Trial Efficiency and Patient-Centered Design at SCOPE US 2026 [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 11/4/25 - Beat
AMGN
Sec Filings
- 1/30/26 - Form 8-K
- 11/21/25 - Form 4
- 11/20/25 - Form 144
- AMGN's page on the SEC website